Key result
Cardiovascular risk factors, metabolic factors, and markers of inflammation were differentially associated with carotid plaque size and echogenicity in 1,016 subjects aged 70 years.
Why the study?
Are traditional cardiovascular risk factors and markers of inflammation and oxidation associated with carotid plaque size and echogenicity in 70-year-old subjects?
Cross-Sectional (n=1,016)
Are traditional cardiovascular risk factors and markers of inflammation and oxidation associated with carotid plaque size and echogenicity in 70-year-old subjects?
Different cardiovascular risk factors influence carotid plaque size versus echogenicity, with metabolic factors driving plaque composition and inflammation driving plaque burden.
Differential associations may refine plaque phenotyping in research; should not yet change clinical practice in older adults.
Carotid plaques can be characterised by ultrasound by size and echogenicity. Both size and echogenicity are predictors of cardiovascular events. The aim of this study was to examine whether traditional risk factors and markers of inflammation and oxidation were associated with plaque size and echogenicity. Computerised analysis of carotid plaque size and echogenicity (grey scale median, GSM) were performed by ultrasound in a population-based health survey in 1,016 subjects aged 70 years (PIVUS study). Information on cardiovascular risk factors was collected, together with markers of inflammation and oxidation. Increased Framingham risk score, systolic blood pressure, higher BMI and decreased HDL, lower glutathione levels were related to echolucent plaques. Previous or present smoking was common with significantly more pack-years related to the echorich plaques. Plaque size was associated with increased Framingham risk score, systolic blood pressure, blood glucose levels, smoking, ApoB/A1 ratio, OxLDL, TNF alpha, HOMA insulin resistance, leucocyte count, decreased BCD-LDL and low levels of l-selectin. Low HDL, increased BMI and decreased glutathione levels were associated with the echolucency of carotid plaques, implying metabolic factors to play a role for plaque composition. Markers of inflammation were related to plaque size alone, implying inflammation to be predominantly associated with the amount of atherosclerosis. These results suggest that plaque size and echogenicity are influenced by different risk factors.
No takes yet. Share an insight, caveat, or question.
Andersson et al. (2009) conducted a cross-sectional in Carotid plaques (n=1,016). Cardiovascular risk factors, inflammation, and oxidation markers was evaluated on Carotid plaque size and echogenicity (grey scale median). Cardiovascular risk factors, metabolic factors, and markers of inflammation were differentially associated with carotid plaque size and echogenicity in 1,016 subjects aged 70 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: